Sumitomo Mitsui DS Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-7,960
Closed -$202K – 777
2022
Q3
$202K Buy
7,960
+104
+1% +$3.65K ﹤0.01% 733
2022
Q2
$261K Hold
7,856
– – 0.01% 719
2022
Q1
$567K Sell
7,856
-41
-0.5% -$2.95K 0.01% 628
2021
Q4
$725K Sell
7,897
-247
-3% -$29.5K 0.02% 599
2021
Q3
$1.03M Sell
8,144
-48
-0.6% -$6.99K 0.02% 494
2021
Q2
$1.36M Buy
8,192
+1,454
+22% +$236K 0.03% 423
2021
Q1
$1.22M Buy
6,738
+96
+1% +$22.3K 0.03% 433
2020
Q4
$1.33M Buy
6,642
+2,408
+57% +$490K 0.04% 391
2020
Q3
$928K Buy
4,234
+688
+19% +$146K 0.03% 430
2020
Q2
$676K Buy
+3,546
New +$621K 0.02% 498

Other funds holding TDOC

Sumitomo Mitsui DS Asset Management's TDOC Position: Q4 2022 in Review

Sumitomo Mitsui DS Asset Management sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 7,960 shares — an estimated $202K sold.

Sumitomo Mitsui DS Asset Management first reported a position in TDOC in Q2 2020 and held it in 10 quarters. The position peaked at $1.36M in Q2 2021. 443 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • Sumitomo Mitsui DS Asset Management reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • Sumitomo Mitsui DS Asset Management sold 7,960 Teladoc Health shares in Q4 2022, an estimated $202K.
  • Sumitomo Mitsui DS Asset Management first reported a position in Teladoc Health in Q2 2020 and held it in 10 quarters.
  • Sumitomo Mitsui DS Asset Management's Teladoc Health position peaked at $1.36M in Q2 2021.
  • 443 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q4 2022, filed 26 Jan 2023.